DarioHealth (DRIO) Tops Q1 EPS by 24c

DarioHealth (NASDAQ: DRIO) reported Q1 EPS of $0.14, $0.24 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $6.75 million versus the consensus estimate of $7.47 million.

For earnings history and earnings-related data on DarioHealth (DRIO) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• B.Riley Downgrades Lantheus Holdings (LNTH) to Neutral
• Fed policy stance keeps Treasury yields high, says Citadel Securities